OncLive: Dr. Mesa on developing racially inclusive clinical trials in MPNs
August 17, 2020
Dr. Ruben Mesa, MD, director of the Mays Cancer Center, discusses the importance of developing racially inclusive clinical trials in myeloproliferative neoplasms (MPNs). Watch the interview.